Is Lysine Good for Shingles? What Science Says

No reliable clinical evidence supports using lysine to treat or prevent shingles. The idea comes from decades-old research on a different herpesvirus, and the leap from cold sores to shingles is bigger than most supplement websites acknowledge. Shingles is caused by varicella-zoster virus (VZV), not herpes simplex virus (HSV), and the two behave differently enough that what works for one cannot simply be assumed to work for the other. Meanwhile, proven treatments for shingles, including antiviral drugs and a highly effective vaccine, have strong evidence behind them.

Where the Lysine-Herpes Connection Comes From

Lysine is an essential amino acid your body cannot make on its own. The theory behind its use against herpesviruses dates back to the 1970s and rests on a simple idea: certain viruses need the amino acid arginine to replicate, and lysine competes with arginine. By flooding your system with lysine, the thinking goes, you starve the virus of the arginine it needs to build new copies of itself. A 2022 review in the British Journal of Clinical Pharmacology described how lysine can interfere with viral capsid protein formation through competitive antagonism with arginine, and can also boost arginase, an enzyme that breaks arginine down faster.¹

This mechanism was studied primarily in the context of herpes simplex, the virus behind cold sores and genital herpes. An often-cited 1983 survey gave lysine supplements to over 1,500 people with cold sores, canker sores, and genital herpes, and found that 84% of respondents reported fewer outbreaks. The average dose was about 936 mg per day.² That sounds promising until you look more closely. The study relied entirely on self-reported questionnaires with no placebo control. People who buy a supplement and take it for six months are primed to believe it is working. Without a comparison group taking a dummy pill, there is no way to separate real antiviral activity from the placebo effect and the natural tendency of outbreaks to come and go on their own.

Why Shingles Is Not the Same as Cold Sores

Both HSV and VZV belong to the herpesvirus family, both hide out in nerve cells after your initial infection, and both can reactivate later. That family resemblance is what makes the lysine-for-shingles idea seem plausible on the surface. But the similarities thin out quickly when you look at the biology.

HSV-1 latency is relatively simple. During dormancy, the virus mostly produces a single set of RNA transcripts called LATs, and the rest of its genome stays quiet. VZV latency is messier. Researchers have detected transcripts from at least a dozen VZV genes in latently infected human nerve tissue, and the virus appears to infect different cell types than HSV does.³ A later review confirmed that while both viruses establish latency in peripheral ganglia, their gene expression patterns during dormancy and the mechanisms of reactivation differ substantially.⁴

Why does this matter for lysine? Because the arginine-dependence that lysine supposedly exploits was characterized in HSV, not VZV. These two viruses use different replication strategies, different latency programs, and different triggers for waking up. A supplement that might theoretically interfere with HSV replication does not automatically do the same to VZV. And as we’ll see, the evidence that lysine even works against HSV is surprisingly weak.

The Evidence Against Lysine Is Stronger Than the Evidence For It

The most rigorous look at lysine for herpes prevention comes from a Cochrane systematic review, which evaluated interventions for preventing cold sores on the lips. The reviewers assessed multiple potential preventive treatments and concluded plainly that they “failed to find any evidence of efficacy for lysine” in preventing outbreaks.⁵ Cochrane reviews are considered the gold standard for synthesizing clinical evidence, so this is not a minor finding. If lysine cannot demonstrate efficacy against the virus it was originally proposed to fight, the case for using it against VZV, a related but distinct virus, becomes vanishingly thin.

No randomized controlled trial has tested lysine specifically against shingles. The handful of case reports and theoretical papers that mention VZV in the context of lysine or arginine are working from lab-bench reasoning, not from evidence gathered in humans with shingles. The entire argument for lysine against VZV is built on an analogy that the best available evidence does not support even in its original context.

The Arginine Side of the Story

If lysine’s supposed benefit comes from suppressing arginine, you might wonder whether high arginine intake could make shingles worse. A few case reports have explored this angle. One documented a young, otherwise healthy person who experienced recurrent herpes zoster affecting the eye while taking high doses of L-arginine.⁶ Another report described recurrent herpes zoster ophthalmicus in a healthy individual who was using anabolic steroids alongside L-arginine supplementation. The authors speculated that arginine may have promoted viral activity while the steroids suppressed the immune response needed to keep the virus in check.⁷

These case reports are interesting but limited. A case report describes what happened to one person and cannot establish cause and effect. The arginine-VZV link in humans remains speculative. Still, these reports do at least suggest that the lysine-arginine balance might matter for herpesviruses in some way. The problem is that “might matter in theory” and “works as a treatment” are separated by a wide gap that no clinical trial has bridged for shingles.

What Actually Works for Shingles

Unlike lysine, antiviral medications have been tested extensively in randomized trials for shingles and proven effective. Acyclovir was the first, and it remains a staple. In a controlled trial, patients treated with acyclovir within 48 hours of their rash appearing saw their pain resolve in a median of about 28 days, compared with roughly 62 days for those on placebo.⁸ That’s cutting pain duration roughly in half.

Valaciclovir, a prodrug that the body converts into acyclovir, offers better absorption and simpler dosing. A large randomized trial comparing the two in adults aged 50 and older found that valaciclovir shortened the median duration of shingles-related pain to about 38 days, compared with 51 days for acyclovir.⁹ Both drugs work by blocking VZV’s ability to copy its DNA. They are most effective when started early, ideally within 72 hours of the rash appearing, though some benefit persists even when treatment starts a bit later.

The difference between these drugs and lysine is not subtle. Antivirals have been through large, placebo-controlled, randomized trials with clear, measurable outcomes. Lysine has not been tested in even a single controlled trial for shingles.

The Shingles Vaccine Changes the Calculus

For prevention, the recombinant zoster vaccine (sold as Shingrix) is in a different league from any supplement. A systematic review and meta-analysis found the vaccine was about 94% effective at preventing shingles and about 91% effective against postherpetic neuralgia, the chronic pain that can linger for months after the rash clears, in adults aged 50 and older.¹⁰ Even in adults 70 and older, where immune function tends to be weaker, efficacy against shingles remained above 91%.

Protection also appears to be durable. An extension study following vaccinated participants for an average of about seven years after their second dose found that efficacy against shingles was still roughly 91% over the entire follow-up period, with annual efficacy estimates holding above 84% between years four and six.¹¹ Real-world effectiveness data from the United States has confirmed that these clinical trial numbers translate outside of controlled settings.¹²

If you are interested in preventing shingles, a conversation with your doctor about vaccination is worth far more than a bottle of lysine.

Is Lysine Safe to Take Anyway?

Some people figure that even if lysine might not help shingles specifically, it’s a harmless amino acid, so why not try it? The safety profile is reasonably reassuring at moderate doses. Two systematic reviews of lysine supplementation in humans found that the main side effects were mild gastrointestinal symptoms like nausea, stomachache, and diarrhea. The risk of developing these symptoms was not significantly higher than placebo, with a risk ratio of 1.02. Both reviews identified a provisional safe upper level of about 6,000 mg per day, the dose below which no adverse effects were observed.¹³¹⁴

There is one caution worth knowing about. An animal study found that very high doses of lysine given to rats over a short period caused acute kidney damage resembling what doctors call acute tubular necrosis. The damage included loss of individual tubular cells and extensive cast formation in kidney structures. Lower doses did not produce these effects, and the doses involved were far above what a human would typically take in supplement form.¹⁵ Still, people with existing kidney problems should be cautious with lysine supplements, and anyone taking high doses long-term should be aware that kidney safety at sustained high intake has not been thoroughly studied in humans.

The broader point is that “safe” and “effective” are different questions. Lysine supplements are unlikely to hurt you at typical doses. But taking something that doesn’t work against your condition is not cost-free either, especially if it delays you from seeking treatments that have actual evidence behind them.

What About Vitamin D and Other Nutrients?

Lysine is not the only supplement that gets promoted for shingles. Vitamin D is another popular suggestion, often based on its known role in immune function. But when researchers looked at whether vitamin D status affects shingles risk in a large population, the answer was disappointing. A study using data from the UK Biobank found that after adjusting for age, sex, and other relevant factors, neither vitamin D deficiency nor insufficiency was associated with a higher risk of developing shingles.¹⁶ A separate systematic review and meta-analysis of vitamin D and human herpesvirus infections found the same thing for herpes zoster specifically: no evidence of an association between vitamin D deficiency and the risk of developing shingles.¹⁷

This does not mean vitamin D is unimportant for your health. It means that correcting a deficiency probably will not lower your shingles risk. The immune factors that keep VZV dormant in your nerve cells appear to be more about cell-mediated immunity, the branch of the immune system that declines with age, than about any single micronutrient you can take in pill form. That’s exactly why the recombinant zoster vaccine, which specifically stimulates a strong cell-mediated immune response against VZV, works so well where supplements have not.

Managing Pain After a Shingles Episode

For people who have already developed shingles, the most dreaded complication is postherpetic neuralgia, a burning or stabbing nerve pain that persists long after the rash has healed. It can last months or even years and is notoriously difficult to treat. Antiviral drugs started early reduce the risk, but they don’t eliminate it entirely.

Treatment for postherpetic neuralgia typically involves medications that target nerve pain. Oral options include drugs like pregabalin. Topical treatments offer an alternative for people who want to avoid systemic side effects. A review of topical treatments for nerve pain found that a high-concentration capsaicin patch demonstrated effectiveness comparable to pregabalin across a range of nerve pain conditions, while a lidocaine patch provided similar pain relief but fell slightly short of formal non-inferiority criteria. Both topical approaches avoided the drowsiness, dizziness, and weight gain that often come with oral nerve-pain medications.¹⁸

Lysine has no demonstrated role in managing postherpetic neuralgia. The pain is driven by nerve damage from the virus, not by ongoing viral replication, so even if lysine’s anti-arginine mechanism had some theoretical antiviral effect, it would be irrelevant to a problem that is fundamentally about damaged nerves, not active infection.

Why the Supplement Narrative Persists

Given how thin the evidence is, you might wonder why lysine for shingles remains so widely recommended online. Part of it is a confusion of categories. Many health sites lump all herpesviruses together, treating cold sores, genital herpes, and shingles as essentially the same problem. Someone reads that lysine “fights herpes” and reasonably assumes it works against the virus causing their shingles. The nuance that HSV and VZV are different viruses with different biology gets lost in the simplification.

Another factor is the nature of shingles itself. It is typically a self-limiting condition. Most episodes resolve on their own within two to four weeks, regardless of treatment. If you start taking lysine when the rash appears and the rash goes away in a couple of weeks, it feels like the lysine worked. This is the same reasoning trap that sustains belief in all sorts of ineffective remedies for conditions that get better on their own.

There is also a publication bias at work. The positive-sounding survey from 1983, where 84% of respondents said lysine helped their herpes, gets cited endlessly on supplement websites.² The Cochrane review finding no evidence of efficacy, a far more rigorous piece of work, rarely makes it into the same marketing copy.⁵ People searching for natural remedies encounter the optimistic claim first and may never see the rigorous counter-evidence.

None of this means that future research could not uncover some role for lysine or amino acid balance in VZV management. Science can surprise you. But right now, the evidence simply is not there. If you are dealing with shingles, your best options are antivirals started as early as possible, appropriate pain management, and vaccination to reduce the risk of recurrence or a first episode. Those are the interventions that have actually been tested against the virus that actually causes shingles, and they work.